StockSwissROP.SW
Roche Holding AG
CHF 360.80
-2.80 (-0.77%)today
Valuation & earnings
- P/E ratio
- 23.52
- Forward P/E
- 16.41
- EPS (ttm)
- CHF 15.34
- Forward EPS
- CHF 21.98
- Price/book
- 8.79
- PEG ratio
- 1.66
- Dividend yield
- 2.7%
- Payout ratio
- 63.93%
Financials (ttm)
- Revenue (ttm)
- 63B
- Revenue growth
- -1.2%
- Profit margin
- 19.6%
- Return on equity
- 38.11%
- Total cash
- 9.7B
- Total debt
- 33.3B
Analyst view
Consensus ratingBuy19 analysts
Strong buy 5Buy 5Hold 7Sell 2
12-month price targetsImplied upside: +4.03%
230
375.34
434.5
LowCurrent priceHigh
Dividends
- Dividend yield
- 2.7%
- Dividend (annual)
- CHF 9.80
- Ex-dividend date
- Mar 12, 2026
Recent payments
Mar 11, 2026 · CHF 9.80Mar 26, 2025 · CHF 9.70Mar 13, 2024 · CHF 9.60Mar 15, 2023 · CHF 9.50Mar 16, 2022 · CHF 9.30
Latest news
(English)Roche and Earendil forge $1.5bn bispecific discovery deal
Pharmaceutical TechnologySep 25, 2026
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
BenzingaSep 24, 2026
Roche targets Novartis on IgAN market after Phase III win
Clinical Trials ArenaSep 24, 2026
MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests
Clinical Trials ArenaSep 24, 2026
Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?
ZacksSep 24, 2026
Merck reveals study success, and possible safety worries, for eye drug hopeful
BioPharma DiveSep 24, 2026
Related products
How visible is Roche Holding AG in AI search?
We ask AI search engines about Roche Holding AG and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Roche Holding AG yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.